NEW YORK (GenomeWeb) – NantHealth reported after the close of the market on Monday that its third quarter revenues rose 76 percent year over year, thanks largely to a 252 percent increase in sales from its software platforms such as NantOS.

For the quarter ended Sept. 30, the company reported revenues of $25.4 million, up from $14.4 million a year earlier. However, it missed Wall Street analysts' average estimate for revenues of $26.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.